Translate this page into:
Soft tissue sarcomas of the proximal adductor area of the thigh: Indications, results and complications at medium follow-up in a series of 43 surgically treated patients
⁎Corresponding author: Alessandra Scotto di Uccio. allascotto@gmail.com
-
Received: ,
Accepted: ,
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
When Soft Tissue Sarcomas are localized in the groin area, they pose specific challenges due to their proximity to important structures. These tumors exhibit elevated complication rates and a higher local recurrence rate compared to their locations in other limbs. The objective of this paper is to analyze a series of patients affected by soft tissue sarcomas in the adductor area of the proximal thigh. The analysis aims to elucidate the epidemiology, diagnostic and therapeutic approaches, complications, and outcomes. Additionally, the study seeks potential prognostic factors and to determine patients at a heightened risk of postoperative complications.
all patients who underwent surgeries for primary soft tissue sarcomas of the adductor area between October 2006 and March 2022 in a tertiary research hospital were valued. Epidemiology, tumor characteristics and therapeutic approaches were analyzed to identify risk factors for complications and local recurrences; survival was considered a secondary outcome.
The series comprised 43 patients, 26 males and 17 females, with an average age of 63.3 years. The most frequent histology was liposarcoma, followed by undifferentiated forms. All patients reported the presence of masses, with associated pain in 27.9% of cases. Limb-sparing surgery was performed in 86.0% of cases. Early and late complications were experienced by 34.9% and 20.0% of patients, respectively, with wound dehiscence being the most frequent problem. The recurrence rate was 9.3%, with no recurrences observed in low-grade patients. At an average follow-up of 51 months, 18 patients (41.9%) were alive, two of which with distant metastases.
The present series provides evidence that when Soft Tissue Sarcomas localized in the groin area are managed in specialized centers, the rates of recurrence and complications are not significantly different from those observed in other anatomical sites.
Keywords
Soft tissue sarcoma
groin
Adductor area
Wide margin
1 Introduction
Soft Tissue Sarcomas (STSs) are a heterogeneous group of malignant tumors originating from various soft tissues, such as muscles, adipose tissue, nerves, and blood vessels. When localized in the groin area, they are considered a distinct subset due to their peculiar anatomical location, unique diagnostic and management challenges.1
This region is particularly complex from an anatomical perspective, given the tumor's proximity to blood vessels, nerves, muscles, and bones (Fig. 1).

Furthermore, the rich lymphatic drainage contributes to the high frequency of seromas and complications related to wound healing, as documented in the literature.1,2
Understanding the specific characteristics of these tumors is essential, due to their potential aggressiveness and the diagnostic and therapeutic challenges they may pose. Early and accurate diagnosis, followed by prompt targeted treatment, are crucial to enhance survival chances and, if possible, preserve the functionality of the adductor region of the thigh.
Moreover, surgeries for these tumors often exhibit elevated postoperative complication rates (ranging from 20% to 68%) along with significant local recurrence rates (ranging from 16% to 48%) compared to their counterparts located in other limb sites.3,4 This tendency could potentially be correlated to the latent and asymptomatic growth of STSs, resulting in substantial enlargement before diagnosis and consequently adding complexity to surgical management. The purpose of this paper is to analyze a series of 43 patients with soft tissue sarcomas of the adductor area of the thigh, elucidating the epidemiology, patients' ages, sex, diagnosis, including specific histotype, diagnostic and therapeutic approaches. We focus on the surgical treatment and related complications and on the patients’ outcomes, aiming to identify any possible prognostic factors and patients at high risk of postoperative complications.
2 Patients and methods
The series comprises all consecutive patients who underwent surgeries for primary STSs of the groin and adductor area between October 2006 and March 2022 in a tertiary research hospital. Exclusion criteria included benign tumors and patients with incomplete data.
Diagnoses were achieved through free-hand biopsies for large and palpable masses, utilizing a rongeur insert through a minimal incision5 or through CT-guided or ultrasound-guided trocar biopsies for smaller and deeper tumors.
The surgical team that conducted the biopsies also performed the subsequent surgeries. All histologies were evaluated by an expert pathologist, trained in musculoskeletal oncology. Histologies were succinctly classified into high-grade and low-grade based on their biological behavior.
Gadolinium-contrasted thigh MRI was performed to assess the mass and its relationship with the neurovascular bundles and bone surfaces, whereas staging for metastases was completed with a total-body CT scan or an FDG-PET scan (Fig. 2).

The tumor volume was measured reconducting it's shape to an ellipse and evaluating the length of the three major axes. The distance from the skin was considered the minimal distance measured on the axial MRI. The Enneking staging system was used for tumor grading and to describe their extension.6 All cases were discussed in a multidisciplinary meeting to assess surgical indication and timing.
Antibiotic prophylaxis with cephazolin 1g was initiated upon the commencement of anesthesia and was subsequently administered every 8 h; this regimen was extended for three days postoperatively. Specific antibiotic treatment was planned if necessary.
Prophylactic administration of low molecular weight heparin was initiated a day before surgery. In cases of possible vessel compression by the tumor, heparin administration was prescribed immediately at the first observation.
Surgical procedures were performed by a consistent team of proficient oncological surgeons. When a vascular bypass was required, a vascular surgeon was also enlisted.
For conservative surgeries, patients were positioned supinely with abducted hips. Flexion was introduced when dealing with tumors located in the posterior-medial aspect of the thigh, particularly when the ischium was involved. The incision site was meticulously planned, considering the tumor's specific anatomical location, with special attention given to excising the biopsy tract. In scenarios requiring hip disarticulation or inter-ileo-abdominal amputation, patients were positioned supine or, respectively, in a “floppy lateral” posture.
Early mobilization of patients was prioritized to minimize muscular atrophy and complications stemming from prolonged immobilization. Nonetheless, weight-bearing was allowed solely after complete wound healing.
Pathology specimens were analyzed by the same pathologist who examined the biopsies. Surgical margins were categorized as wide, marginal, or intralesional.
Complications were classified as “early” or “late” based on whether they manifested within or after 30 days following surgery, respectively. Wound dehiscence was defined as a partial or complete separation of wound edges, often attributable to ischemic or infectious issues.
Blood loss was categorized as “hemorrhage” when surgical intervention was imperative for its resolution, and as “anemia” when it only required blood transfusion support.
Respiratory complications encompassed pulmonary lacerations, pneumonia, and pulmonary embolism. Urological issues included urethral damage.
The Clavien-Dindo classification was used to grade the severity of complications.7
Follow-up appointments were scheduled at three-month intervals for the initial two years, every four months in the third year, and semiannually during the fourth and fifth years for high-grade histologies. Subsequently, annual appointments were arranged for an additional five years. For low-grade tumors, follow-up appointments were set at four-month intervals during the first year, subsequently every six months until the fifth year and then annually for the following five years. Nevertheless, deviations in the follow-up schedule were conceivable based on distinct histologies and individual considerations.
The functional results were assessed using the Musculoskeletal Tumor Society (MSTS) Score and the Toronto Extremity Salvage Score (TESS) for the lower limb.8,9
2.1 Statistical methods
Descriptive statistics were used to summarize pertinent study information. Median follow-up was estimated with the Kaplan-Meier reverse method. Overall Survival (OS), Disease-Free Survival (DFS) and Local Recurrence-Free Survival (LRFS) were calculated by the Kaplan-Meier product-limit method from the date of the surgery until relapse or death. If a patient was not dead, survival was censored at the time of the last visit. DFS and LRFS were calculated from the date of surgery to the date of relapse or death. If a patient had not relapsed, DFS and LRFS were censored at the time of the last visit. The log-rank test was used to assess differences between subgroups. The Hazard Ratio, Odds Ratio and the confidence limits were estimated for each variable of interest outcome, using the Cox univariate model and logistic regression model, respectively. Significance was defined at the p < 0.05 level.
Gender, age, previous therapy, operating room time, tumor volume, blood loss, transfusion, hospital stay and radiotherapy were tested in univariate analysis for the early and late complications outcomes.
Gender, age, previous therapy, margin and tumor volume were tested in univariate analysis for the DFS, LRFS and OS outcomes.
A multivariate Cox proportional hazard model was also developed using stepwise regression (forward selection) with predictive variables which were significant in the univariate analyses. Enter limit and remove limit were p = 0.10 and p = 0.15 respectively. The SPSS (version 21.0; SPSS, Inc., Chicago, IL) a licensed statistical program was used for all analyses.
2.2 Ethics
All patients gave their consent to be included in the study and for its publication. This study received clearance from the institutional review board. It was designed in compliance with the Declaration of Helsinki's guiding principles and the ethical guidelines of the relevant Committee on Human Experimentation.
3 Results
3.1 Epidemiology
The series comprised 43 patients, including 26 males and 17 females, with an average age of 63.3 years (range: 30.3–101.2; median: 64.5). Detailed epidemiological data are presented in Table 1.
| Parameters | Value |
| Patients | 43 (26 M–17F) |
| Age | Mean: 63.3 years (range: 30.3–101.2; median: 64.5) |
| Sites | |
| Proximal third of the thigh | 10 |
| Medium third of the thigh | 11 |
| Proximal and medium third of the thigh | 6 |
| Medium and distal third of the thigh | 7 |
| Whole medial compartment of the thigh | 9 |
| Enneking Classification | |
| Intracompartmental | |
| IA | 7 |
| IIA | 25 |
| Extracompartmental | |
| IB | 1 |
| IIB | 5 |
| III | 5 |
| Symptoms | |
| Mass | 43 |
| Pain | 12 |
| Diagnosis | |
| Liposarcoma 16 | |
| - myxoid 6 (3HG – 3LG) | |
| - well differentiated liposarcoma 5 (5LG) | |
| - pleomorfic 3 (2HG – 1LG) | |
| - undifferentiated 2 (2HG) | |
| Undifferentiated Sarcoma 8 (7HG pleomorphic – 1HG Spindle cells) | |
| Monofasic Synovial Sarcoma 4 | |
| Myxofibrosarcoma 4 (3HG – 1LG) | |
| Leiomyosarcoma 3 (2HG pleomorphic – 1LG) | |
| Malignant peripheral nerve Sheath tumor 2 (2HG) | |
| Extraskeletal Osteosarcoma 2 (2HG) | |
| extra-skeletal myxoid chondrosarcoma 1 (1HG) | |
| Malignant mesenchimal tumor 1 (1HG) | |
| Solitary Fibrous Tumor 1 (1HG) | |
| Spindle cells Sarcoma 1 (1HG) | |
| Surgery | |
| limb-sparing surgery | 37 |
| Inter-ileo-abdominal amputation | 6 |
| Obtained Surgical Margin | |
| Wide | 42 |
| Marginal | 1 |
| Intralesional | 0 |
| Blood transfusions | 2.5 units (range: 1–5, median: 2.5) |
| Early Complications | Late complications |
| Wound dehiscence: 9 | Wound dehiscence: 4 |
| Fever: 4 | Hemorrhage: 1 (surgically treated) |
| Anemia: 3 | Pneumonia: 2 |
| Neurologic problems: 3 | Fever: 1 |
| Pulmonary embolism: 1 | Pulmonary embolism: 1 |
| Hematuria: 1 | |
| Thrombocytopenia: 1 | |
| Intestinal perforation: 1 | |
| Hemorrhage: 2 (surgically treated) | |
| Sepsis: 2 |
3.2 Site and involvements
The predominant tumor location was the anterior-medial region of the adductor area in 40 patients, while three cases exhibited involvement of the posterior-medial segment. Tumors were located in the proximal third of the thigh in 10 patients, in the middle third in 11 cases, in the proximal and middle third in 6 cases whereas in the middle and distal third in 7 cases. The entire medial compartment was compromised in 9 cases. The average tumor volume was 959.05 cm³ (range: 31–4337 cm³, median: 550.00 cm³).
Sarcomas adhered to the femur in 13 cases, three of them had also invaded the ileum and ischium-pubic rami. In one case, the tumor only adhered to the ileum and ischium-pubic rami. The femoral vascular bundles were involved in 22 cases, with varying degrees. The femoral nerve was compromised in 14 cases (Fig. 3), and in three of these cases, the sciatic nerve also adhered. The sciatic nerve alone was involved in six cases.

In the case with the second most bulky tumor of the series, both the sciatic and the femoral nerves, as well as the femur and pelvic bones and the vascular bundles were involved. The minimal distance from the skin surface was available for 24 patients, with an average value of 13 mm (range: 0–47, median: 8).
3.3 Symptoms
All patients complained about the presence of masses, which were associated with pain in 12 cases (Table 1).
3.4 Diagnosis
Diagnoses were achieved through a preoperative biopsy in all cases. The histology revealed a low-grade tumor in 12 cases and a high-grade tumor in 30 cases. In one case, a benign Schwannoma was diagnosed on the preoperative biopsy; nevertheless, it was included in the present review because it was approached as a high-grade sarcoma due to the heightened suspicion arising from preoperative imaging and confirmed upon definitive histology. Specific preoperative histologies are reported in Table 1.
The tumor was localized in all cases except for three: metastases were detected in the groin lymph nodes and lungs in one case of high-grade undifferentiated sarcoma, in the groin lymph nodes and bones in a case of malignant peripheral nerve sheath tumor, and in the bones in a case of extra-skeletal myxoid chondrosarcoma.
3.5 Chemotherapy
Sixteen out of 32 patients affected by high-grade tumors (50.0%) underwent chemotherapy. Neoadjuvant chemotherapy was performed in 11 cases, followed by adjuvant chemotherapy in two cases; in five cases, exclusive postoperative chemotherapy was administered.
3.6 Radiotherapy
Nineteen cases received radiotherapy, including neoadjuvant in three cases, intraoperative in one case, and postoperative in 15 cases.
3.7 Surgeries
Limb-sparing surgery was performed in 37 cases (86%), including a vascular bypass in three cases due to femoral vessel involvement, preventive intramedullary nailing in one case, and en-bloc femoral resection with prosthetic reconstruction in eight cases. External hemipelvectomy was performed in six cases due to mass volume and involvement of the femur. The wounds were closed directly, without using local or free flaps. The duration of surgeries averaged 206.3 min (range: 60–720, median: 180). Drains were removed on the fifth postoperative day on average (range: 2–10, median: 4).
3.8 Pathological results
Margins were wide in all cases except for one considered marginal (2 mm). The diagnoses made based on the preoperative biopsies were confirmed by the definitive histologies in 33 out of 43 cases (77.6%). In 7 cases (16.2%), the definitive histology confirmed the grade but not the specific histotype; however, the treatment administered was still appropriate. In three cases (6.9%), the biopsies underestimated the tumor grade, resulting in undertreatment of patients due to the absence of neoadjuvant treatment.
3.9 Early complications (Table 2)
Fourteen out of 43 patients (32.5%) developed early complications, including one grade 1, five grade 2, five grade 3, and three grade 4, accordingly to the Clavien-Dindo classification. The most common adverse event was wound dehiscence, observed in nine patients, with surgical revision required in five of them and subsequent application of a Vacuum-Assisted Closure (VAC) system in two cases; the VAC system alone was used in one case. Fever and anemia occurred in three cases each.
Two patients, aged 77.7 years and 89.3 years, diagnosed with undifferentiated pleomorphic sarcoma and pleomorphic liposarcoma, respectively, passed away in the first postoperative month due to sepsis. The specific site of the disease was not statistically associated with the early complication rate (p = 0.927). However, adherence to the femur was statistically associated with the early complication rate (p < 0.001). The lesion was found to be adherent to the femur in 10 out of the 14 patients with early complications (76.9%).
3.10 Late complications (Table 2)
Nine out of 43 patients (20%) developed late complications, including two grade 1, three grade 2, three grade 3, and one grade 4 according to the Clavien–Dindo classification.
The most common late complication was wound dehiscence, that occurred in four cases (with one case also reporting a vast seroma), treated with surgical revision in one case. The specific site of the disease was not statistically associated with the late complication rate (p = 0.999).
Three patients, aged 72, 58, and 63 years, all affected by high-grade tumors, passed away due to late complications, mainly related to respiratory problems. Specifically, two patients succumbed to pneumonia, and one to pulmonary embolism.
3.11 Blood support
Ten out of 43 patients (23.3%) received blood transfusions; an average of 2.5 units were administrated (range: 1–5, median: 2.5).
Among the patients who had early complications, 8 patients had received transfusions, 6 patients had not. This difference was statistically significant (p < 0.001). Therefore, receiving blood transfusions increased the risk of developing early complication.
3.12 Length of hospitalization
The average inpatient stay was 19.3 days (range: 5–95, median: 13). Considering the groups with and without complications, the length of admission was 27.7 days (range: 8–95, median: 16) and 13.8 days (range: 5–65, median: 12), respectively. When considering the group with only early complications, the average inpatient stay was 31.9 days (range: 12–95, median: 30) (p < 0.001). These data indicate that early complications, usually the most serious, are those that most influence the length of hospitalization; otherwise, late complications are managed in an outpatient setting.
3.13 Recurrences
Four local recurrences were reported at 3, 10, 11, and 20 months from index surgeries, all in cases with high-grade tumors. They were located in the proximal third of the thigh, the whole medial compartment of the thigh, and two in the medial third of the thigh. Both the specific site and adherence to the femur were not statistically associated with the recurrence rate (p: 0.999 and 0.572, respectively). The 5-year local recurrence-free survival was 89.0%; the related Kaplan-Meier curve is shown in Fig. 4.

3.14 Metastases
Fifteen out of 43 patients developed distant metastases, five of these patients were already metastatic and were treated surgically for palliation; the average time of metastasis onset was 15.3 months (range: 0–70, median: 8).
The specific locations of metastases were lungs in 80% of cases, bones in 33%, nodes and the brain in 13.3% and 7.0% of cases, respectively; 33.0% had various other sites of metastases.
The 5-year Distant Metastasis-Free Survival (DMFS) was 65.8%. The related Kaplan-Meier curve is shown in Fig. 4. In this series, only high grading is associated with a higher rate of late metastases (p = 0.017).
3.15 Survival
At an average follow-up of 51 months, 18 out of 43 patients (41.9%) were alive, two of which with distant metastases. Twenty-five patients died, seven for causes not related to the diseases (six due to senescence and one due to complications related to dialysis). Five patients died in the first five months due to complications related to surgery, including two from sepsis, two from pneumonia, and one from pulmonary embolism. Twelve patients died due to disease progression, and one due to sepsis at 48 months from the index surgery. The 5-year Overall Survival (OS) was 41.5%, whereas the 5-year Disease-Related Survival (DRS) was 52.2%; the corresponding values at 10 years were 37.6% and 48.8% (Fig. 4).
3.16 Functional results
The MSTS score and the TESS were evaluated in 14 patients; the average values were 83.3% and 81.5%, respectively.
4 Discussion
Soft tissue sarcomas are quite rare, comprising only 1% of the spectrum of adult malignant tumors. In Europe, the annual occurrence of STSs stands at a rate of 4.5 fresh occurrences per 100,000 inhabitants.10 The concern of STS arises in patients who manifest a soft tissue mass exceeding 5 cm, characterized by either progressive enlargement or a subfascial location, irrespective of the presence of pain.
The treatment is centered on the diagnosis, which must be histologically based to perform possible neoadjuvant treatment such as chemotherapy and, most recently, radiotherapy. Biopsy is a mandatory step and must be carried out considering the surgical incision; in this series, biopsy demonstrated to be effective in choosing the right surgical approach. Indeed, if the determination of the specific histology was verified in 78.7% of cases, the right grade was detected in 93.1% of cases, allowing for a correct multimodal approach.
While low-grade sarcomas can often be managed through direct surgical excision with a wide margin, high-grade tumors may necessitate neoadjuvant interventions such as radiotherapy, chemotherapy, or a combination of both.
The decision regarding the implementation of preoperative treatment is contingent upon various patient-specific factors, including age, performance status, and disease attributes such as location in relation to the fascia, diameter (whether greater or less than 5 cm), and the availability of effective treatments or experimental protocols.
Currently, the standard treatment for localized soft tissue sarcomas is surgery, as stated by the guidelines of the National Comprehensive Cancer Network.11
Additionally, the guidelines suggest contemplating neoadjuvant or postoperative adjuvant chemotherapy as potential choices for addressing high-grade and sizable tumors. Given the conflicting outcomes documented in clinical trials examining perioperative chemotherapy for localized STSs, the guideline acknowledges the existing evidence and consensus as falling under category 2B classification. A combination of anthracycline and ifosfamide is recommended.12
The guidelines of The European Society of Medical Oncology do not consider perioperative chemotherapy as a routine treatment but as a potential option for high-risk patients.13
Neoadjuvant chemotherapy presents the possible advantage of decreasing the tumor size, allowing for a safer, easier, and less invasive surgery. This concept is particularly crucial for STSs of the groin and adductor area, where a significant effect on tumor size could mean sparing neurovascular bundles. Nevertheless, it is crucial that the patient's overall health status and age permit the administration of neoadjuvant treatment at a full dose to be effective. Otherwise, such an approach could merely result in postponing surgeries and potentially exacerbating the patient's frailty.
In the present series, among the 32 patients affected by high-grade histologies, chemotherapy was performed in 16 cases, including neoadjuvant in nine cases, both neoadjuvant and adjuvant in two cases, and only adjuvant in five cases.
Advanced age is the primary reason for not performing chemotherapy; 11 out of 32 patients did not undergo chemotherapy due to age limitations, one patient had a chemo-resistant histology (extra-skeletal myxoid chondrosarcoma), two patients died from complications in the immediate postoperative months, and 2 patients were in poor clinical conditions.
Radiotherapy has emerged as a cornerstone in achieving effective local control in STSs of the groin. The anatomical constraints and proximity to vital structures often make achieving clean surgical margins challenging. The adjunctive use of radiotherapy allows for dose escalation to the tumor while sparing surrounding healthy tissues. This approach enhances the chances of achieving complete local control and minimizes the risk of local recurrence.
Radiotherapy is typically recommended for cases involving high-grade radiosensitive tumors exceeding 5 cm in size and situated deep to the muscular fasciae. Currently, despite the availability of numerous schedules in the literature, definitive treatment protocols remain somewhat ambiguous. While chemotherapy is typically reserved for high-grade tumors, radiotherapy is deemed appropriate for both low-grade and high-grade histologies. In the current series, radiotherapy was administered for low-grade tumors intraoperatively and postoperatively in one and three cases, respectively.
Recent studies emphasize the significance of neoadjuvant radiotherapy in minimizing the extent of irradiated tissue and facilitating a reduction in tumor size, thereby enabling the preservation of adjacent structures.14 However, it is important to acknowledge the potential increment in postoperative complications, particularly wound dehiscence, edema, and lymphedema, which are among the challenges associated with irradiation of the groin area.
Furthermore, the optimal timing for surgery after neoadjuvant treatment remains uncertain. The chronology of radiation, chemotherapy, and surgical resection appears to have no influence on the success of reconstructive procedures, such as microsurgical tissue transfers. Most surgeons prefer postoperative radiation because it may have decreased risks of wound complications. In cases of neoadjuvant radiation, free flaps may be performed for soft-tissue reconstruction. Several studies have shown superior functional outcomes with preoperative, rather than postoperative radiotherapy. Pre- and postoperative irradiation mainly affects plastic surgery procedures in terms of impaired wound healing and fibrosis.15,16
Obviously, postoperative radiotherapy does not interfere with surgery; however, its administration should ideally follow complete wound closure to mitigate any associated complications that might hinder its implementation. Additionally, it is crucial to extend the radiation field to encompass the entire operative site rather than focusing solely on the area of the mass.
Intraoperative and postoperative radiotherapy is advisable, especially when the quality of the margin was judged at risk of local relapse. Surgery results are fundamental, and the obtained margin can be considered the main prognostic factor.
Kikuta et al. retrospectively analyzed 30 patients with recurrent MFS. They described a 5-year recurrence-free survival rate of 9.8% and 62.3% for those with a positive histological margin and those with a negative margin, respectively. These data indicate that a positive margin is a significant predictor of a poor prognosis.17
This series demonstrates that STSs of the groin area are correctly approached when all professional figures are present, and surgeries are programmed. An oncologically adequate margin was obtained in all our cases, thanks to the possibility to perform vascular bypass or resect the bone when necessary. The thigh is the most common site for STSs, particularly the adductor area.18
The present series confirms this data, considering that more than 90% of tumors are located in the medial aspect. Tumors located in this area can consistently increase their size before becoming symptomatic; indeed, the main symptom is sensing the mass, followed by local pain in the late stages.
Vessel compromise is quite common, given that there is contact with the main vascular bundle in more than 50% of tumors; nevertheless, in most cases, they are cleavable, and vascular bypass is rarely necessary (three out of 42 patients). The choice to perform it is not yet codified in the literature; it depends on the extent of tumor contact and specific histologies; a low-grade tumor allows for vessel sparing in most cases, considering that local recurrences only occur in high-grade tumors. Moreover, performing neoadjuvant treatment could allow tumor excision with a thinner safety margin.
Nonetheless, the potential for significant complications must be weighed meticulously during surgical planning. The prospect of potential wound dehiscence warrants careful consideration due to its potentially life-threatening implications for both limb viability and patient survival.
In situations where the femoral vessels are compromised, and reconstructive surgery is deemed unsuitable due to the patient's general health status or concurrent functional impairment arising from femoral and sciatic involvement, conservative treatment becomes untenable. In such cases, hip disarticulation or inter-ileo-abdominal procedures emerge as the only viable solutions.
Groin tumors can also adhere to bone surfaces such as the ileo-pubic and ischio-pubic rami, the ischiatic tuberosity and the femur.
While detaching the mass from the bone through a subperiosteal dissection could be considered for low-grade histologies, bone resection is mandatory for high-grade sarcomas. Bone involvement has to be considered, and a correct surgical approach planned; while the ischium and the ileo-pubic rami can be easily sacrificed, femoral adherence has to be accurately evaluated.
When the tumor adheres to less than 50% of the femur's circumference, a hemidiaphysis resection en-bloc with the tumor must be considered, after inserting an intramedullary nail into the femur before the tumor extirpation surgery. Currently, carbon-fiber nails are advisable because they do not interfere with eventual postoperative radiotherapy.19
When the tumor adheres to more than half of the circumference of the femur, partial resection can pose too high a risk, and a complete diaphyseal or proximal femur en-bloc resection and related reconstruction with massive homograft or megaprosthesis is recommended.
Surgery for metastatic patients is indicated to control symptoms or bridge to chemotherapy. In these patients, obviously, surgery only has a palliative purpose.
4.1 Complications
The identification of patients at risk of complications also plays an important role in the prevention of major negative events; in the present series, age (p < 0.005), the number of transfusions (p < 0.001), and femur bone involvement (p < 0.001) represent important risk factors for early complications. Bisson-Patoué et al., in a series of 55 patients affected by sarcomas of the groin area, underlined the importance of smoking (p = 0.002), bone exposure (p = 0.057), and obesity (p = 0.053) as predictive factors for major complications.20
4.2 Recurrence
The current series provides evidence that a wide margin remains crucial even within this intricate region. Meticulous surgical planning is imperative to minimize intralesional margins. In this series, where consistent margins were achieved, tumor grade emerges as the predominant risk factor for recurrences. Notably, all four reported recurrences occurred in the context of high-grade sarcomas, even in cases with wide margins. The findings of this series underscore the necessity of maintaining a heightened level of suspicion during the initial two years to promptly identify local recurrences that might still be amenable to limb-sparing surgical interventions. Indeed, all recurrences occurred within the first two years of follow-up.
4.3 Metastases
It is noteworthy to emphasize that in this series, even low-grade sarcomas, despite their low recurrence rates, exhibit a significant susceptibility to distant metastases. Remarkably, over half of the cases involving low-grade tumors manifested distant metastases. The most frequent distant metastasis site was the lung (80%).
All instances of metastatic spread were observed within the initial 70 months. Notably, the survival curves underscore that the initial five years pose a heightened risk in relation to the depth of the disease. After this period, disease-related adverse events become infrequent.
4.4 Functional outcomes
Patients who underwent hip disarticulation or inter-ileo-abdominal amputation achieved lower scores on the MSTS and Toronto Extremity Savage Score.
Surgery typically leads to a reduction in adduction function with minimal impact on normal walking, except in cases where the femoral and/or sciatic nerves are compromised due to their involvement in the disease.
5 Conclusions
Surgery for the excision of soft tissue sarcoma in the groin area is associated with potential complications, including wound-related issues, infection, nerve and vascular injuries, lymphedema, functional impairments, and recurrence. A comprehensive understanding of these complications, their contributing factors, and preventive strategies is indispensable for optimizing patient outcomes and guiding future research endeavors in this field. Gathering patients with soft tissue sarcoma at specialized reference centers, where a comprehensive team of specialists is available, is essential today to ensure a multidisciplinary approach, thus guaranteeing improved oncological and functional outcomes.
Ethical statement
This study received clearance from the institutional review board. It was designed in compliance with the Declaration of Helsinki's guiding principles and the ethical guidelines of the relevant Committee on Human Experimentation.
Funding statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Patient's consent
All patients gave their consent to be included in the study and for its publication.
CRediT authorship contribution statement
Chiara Pagnoni: Conceptualization, Methodology, Validation, Investigation, Resources, Writing – original draft. Giovanni Zoccali: Investigation, Data curation, Writing – review & editing. Alessandra Scotto di Uccio: Conceptualization, Data curation, Writing – review & editing, Visualization. Francesca Sperati: Conceptualization, Formal analysis, Writing – review & editing. Leonardo Favale: Validation, Investigation, Resources, Data curation, Writing – review & editing. Sergio Valeri: Validation, Investigation, Resources, Data curation, Writing – review & editing. Alessio Annovazzi: Validation, Investigation, Resources, Data curation, Writing – review & editing. Maria Grazia Petrongari: Validation, Investigation, Resources, Data curation, Writing – review & editing. Vincenzo Anelli: Validation, Investigation, Resources, Data curation, Writing – review & editing. Virginia Ferraresi: Validation, Investigation, Resources, Data curation, Writing – review & editing. Carmine Zoccali: Conceptualization, Methodology, Validation, Investigation, Resources, Writing – original draft, Writing – review & editing, Supervision, Project administration.
References
- Soft tissue sarcoma at the adductor compartment of the thigh may have a greater risk of tumor-associated events and wound complications. J Orthop Surg. 2019;27(2)
- [Google Scholar]
- Superficial lymphatic drainage of the lower extremity: anatomical study and clinical implications. Plast Reconstr Surg. 2013;132(3):696-707.
- [Google Scholar]
- Soft tissue sarcomas of the groin: diagnosis, management, and prognosis. J Am Coll Surg. 2001;193(2):130-136.
- [Google Scholar]
- Lower extremity salvage after radical resection of malignant tumors in the groin and lower abdominal wall. J Am Coll Surg. 1997;185(3):260-267.
- [Google Scholar]
- A new technique for biopsy of soft tissue neoplasms: a preliminary experience using MRI to evaluate bleeding. Minerva Med. 2015 Apr;106(2):117-120.
- [Google Scholar]
- Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213.
- [Google Scholar]
- A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241-246.
- [Google Scholar]
- Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res: Int J Quality Life Aspect Treatment Care Rehabil. 1996;5(5):508-516.
- [Google Scholar]
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol: Off J European Soc Med Oncol. 2014;25(Suppl 3):iii102-iii112.
- [Google Scholar]
- Chemotherapeutic drugs for soft tissue sarcomas: a review. Front Pharmacol. 2023 Aug 11;14
- [Google Scholar]
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol: Off J European Soc Med Oncol. 2018;29(Suppl 4):iv51-iv67.
- [Google Scholar]
- Tumour volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma. Eur J Surg Oncol. 2014;40(4):394-401.
- [Google Scholar]
- Plastic surgery in the multimodal treatment concept of soft tissue sarcoma: influence of radiation, chemotherapy, and isolated limb perfusion on plastic surgery techniques. Front Oncol. 2015 Dec 1;5:268.
- [Google Scholar]
- Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomized trial. Lancet. 2002;359:2235-2241.
- [Google Scholar]
- A histological positive margin after surgery is correlated with high local re-recurrence rate in patients with recurrent myxofibrosarcoma. Jpn J Clin Oncol. 2017;47(4):334-341.
- [Google Scholar]
- The advantages of carbon fiber based orthopedic devices in patients who have to undergo radiotherapy. Acta Biomed: Atenei Parmensis. 2020;91(3)
- [Google Scholar]
- Factors associated with complications after resection of soft tissue sarcomas of the groin. Orthopaed Traumatol Surg Res : OTSR. 2022;108(4)
- [Google Scholar]

